Cathie Wood’s ARK Invest Buys Over 2.1 Million Shares of Ginkgo Bioworks

A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Thursday. Specifically, these funds bought roughly $15 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these ETFs were down on Thursday.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 698,931 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 1,426,097 shares. At Thursday’s closing price, this would have valued the sales at roughly $14.7 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 46% and the other is down 38% in the past year.

Check out all the ARK Invest purchases for Thursday as well:

FundTickerNameShares
ARKGBNRBURNING ROCK BIOTECH4,000
ARKGDNAGINKGO BIOWORKS698,931
ARKGNRIXNURIX THERAPEUTICS44,628
ARKGNTLAINTELLIA THERAPEUTICS25,739
ARKGPSNLPERSONALIS59,000
ARKGQSIQUANTUM-SI101,895
ARKGRXRXRECURSION PHARMACEUTICALS28,000
ARKKSQBLOCK121,727
ARKKPLTRPALANTIR TECHNOLOGIES430,339
ARKKPATHUIPATH184,626
ARKKNVTAINVITAE57,198
ARKKNTLAINTELLIA THERAPEUTICS63,440
ARKKVCYTVERACYTE29,411
ARKKHOODROBINHOOD MARKETS487,263
ARKKZMZOOM VIDEO COMMUNICATIONS43,550
ARKKDNAGINKGO BIOWORKS1,426,097
ARKKCOINCOINBASE GLOBAL35,390
ARKKCGENCOMPUGEN89,164
ARKKBEAMBEAM THERAPEUTICS42,300
ARKKTWLOTWILIO32,533
ARKQAVAVAEROVIRONMENT20,101
ARKWROKUROKU18,074
ARKWTWOU2U13,011
ARKXMKFGMARKFORGED34,624

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

Source: Read Full Article